Synapse Biomedical Overview
- Year Founded
-
2002

- Status
-
Private
- Employees
-
32

- Latest Deal Type
-
Later Stage VC
- (Cancelled)
- Investors
-
3
Synapse Biomedical General Information
Description
Developer of diaphragm pacemakers designed to research, develop, and commercialize life-altering neurostimulation products for clinicians. The company's products focus on the treatment of neurodegenerative diseases and amyotrophic lateral sclerosis (ALS) through the use of diaphragm pacing systems (DPS) and other systems, enabling clinicians to reach beyond current methods of treatment to meet the ventilatory needs of people dependent on mechanical ventilation due to spinal cord injuries.
Contact Information
Website
www.synapsebiomedical.comCorporate Office
- 300 Artino Street
- Oberlin, OH 44074
- United States
Corporate Office
- 300 Artino Street
- Oberlin, OH 44074
- United States
Synapse Biomedical Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Later Stage VC | 20-Dec-2022 | Cancelled | Generating Revenue | |||
8. Secondary Transaction - Private | 01-May-2021 | Completed | Generating Revenue | |||
7. Debt - PPP | 07-Apr-2020 | Completed | Generating Revenue | |||
6. Later Stage VC (Series D) | 01-Jan-2015 | Completed | Generating Revenue | |||
5. Grant | 18-Dec-2013 | Completed | Generating Revenue | |||
4. Later Stage VC (Series C) | 09-Feb-2010 | Completed | Generating Revenue | |||
3. Early Stage VC (Series B) | 13-Apr-2006 | Completed | Generating Revenue | |||
2. Early Stage VC (Series A) | 20-Sep-2005 | $550K | $6.3M | Completed | Generating Revenue | |
1. Angel (individual) | 16-Dec-2003 | $5.75M | $5.75M | Completed | Startup |
Synapse Biomedical Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series D | ||||||||
Series C | ||||||||
Series B | 3,522,117 | $0.010000 | $0.06 | $0.77 | $0.77 | 1x | $0.77 | 13.21% |
Series A | 919,633 | $0.010000 | $0.64 | $0.64 | 1x | $0.64 | 3.45% |
Synapse Biomedical Comparisons
Industry
Financing
Details
Synapse Biomedical Competitors (1)
One of Synapse Biomedical’s competitors is Lungpacer, a Venture Capital-Backed company based in Vancouver, Canada.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Lungpacer | Venture Capital-Backed | Vancouver, Canada |
Synapse Biomedical Patents
Synapse Biomedical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230001201-A1 | Systems and methods for treating sleep apnea using neuromodulation | Pending | 29-Jan-2019 | ||
US-11471683-B2 | Systems and methods for treating sleep apnea using neuromodulation | Active | 29-Jan-2019 | ||
US-20200238084-A1 | Systems and methods for treating sleep apnea using neuromodulation | Active | 29-Jan-2019 | ||
US-20180036033-A1 | Systems and methods for electrode placement in deep muscles and nerves using ultrasound guidance | Inactive | 03-Aug-2016 | ||
US-8478412-B2 | Method of improving sleep disordered breathing | Active | 30-Oct-2007 | A61N1/3601 |
Synapse Biomedical Signals
Synapse Biomedical Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Ohio Third Frontier | Limited Partner | |||
Vivo Capital | Venture Capital | Minority | ||
Jumpstart Ventures | Venture Capital | Minority |
Synapse Biomedical FAQs
-
When was Synapse Biomedical founded?
Synapse Biomedical was founded in 2002.
-
Where is Synapse Biomedical headquartered?
Synapse Biomedical is headquartered in Oberlin, OH.
-
What is the size of Synapse Biomedical?
Synapse Biomedical has 32 total employees.
-
What industry is Synapse Biomedical in?
Synapse Biomedical’s primary industry is Therapeutic Devices.
-
Is Synapse Biomedical a private or public company?
Synapse Biomedical is a Private company.
-
What is Synapse Biomedical’s current revenue?
The current revenue for Synapse Biomedical is
. -
How much funding has Synapse Biomedical raised over time?
Synapse Biomedical has raised $20.1M.
-
Who are Synapse Biomedical’s investors?
Ohio Third Frontier, Vivo Capital, and Jumpstart Ventures have invested in Synapse Biomedical.
-
Who are Synapse Biomedical’s competitors?
Lungpacer is a competitor of Synapse Biomedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »